Socioeconomic determinants of respiratory health in patients with cystic fibrosis: implications for treatment strategies

References

• Cystic Fibrosis Foundation Patient Registry 2019 Annual data report. Bethesda, MD: Cystic Fibrosis Foundation, 2020.
   Google Scholar
• Collaco JM, Blackman SM, McGready J, et al. Quantification of the relative contribution of environmental and genetic factors to variation in cystic fibrosis lung function. J Pediatr. 2010;157(5):802–807.
   PubMed Web of Science ®Google Scholar
• Ratjen F, Doring G. Cystic fibrosis. Lancet. 2003;361(9358):681–689.
   PubMed Web of Science ®Google Scholar
• Collaco JM, Vanscoy L, Bremer L, et al. Interactions between secondhand smoke and genes that affect cystic fibrosis lung disease. JAMA. 2008;299(4):417–424.
   PubMed Web of Science ®Google Scholar
• Wolfenden LL, Schechter MS. Genetic and non-genetic determinants of outcomes in cystic fibrosis. Paediatr Respir Rev. 2009;10(1):32–36.
   PubMed Web of Science ®Google Scholar
• Oates GR, Schechter MS. Socioeconomic status and health outcomes: cystic fibrosis as a model. Expert Rev Respir Med. 2016;10(9):967–977.
   PubMed Web of Science ®Google Scholar
• O’Connor GT, Quinton HB, Kahn R, et al. Case-mix adjustment for evaluation of mortality in cystic fibrosis. Pediatr Pulmonol. 2002;33(2):99–105.
   PubMed Web of Science ®Google Scholar
• Braveman P, Gottlieb L, Snyder A. The social determinants of health: it’s time to consider the causes of the causes. 433021. 2014;129 Suppl 4:129.
   Google Scholar
• Marmot M, Allen JJ. Social determinants of health equity. Am J Public Health. 2014;104(S4):S517–S9.
   PubMed Web of Science ®Google Scholar
• Braveman P, Egerter S, Williams DR. The social determinants of health: coming of age. Annu Rev Public Health. 2011;32(1):381–398.
   PubMed Web of Science ®Google Scholar
• Braveman PA, Egerter SA, Mockenhaupt RE. Broadening the focus: the need to address the social determinants of health. Am J Prev Med. 2011;40(1):S4–S18.
   PubMed Web of Science ®Google Scholar
• Brennan Ramirez L, Baker EA, Metzler M. Promoting health equity: a resource to help communities address social determinants of health. Journal of Public Health Management and Practice : JPHMP. 2008;14(2):124–130.
   PubMedGoogle Scholar
• Closing the gap in a generation: health equity through action on the social determinants of health. Final Report of the Commission on Social Determinants of Health. Geneva, Switzerland: World Health Organization, 2008.
   Google Scholar
• Solar O, Irwin A. A conceptual framework for action on the social determinants of health. In: Social determinants of health discussion paper 2 (Policy and Practice). Geneva Switzerland: World Health Organization; 2010.
   Google Scholar
• Alderwick H, Gottlieb LM. Meanings and misunderstandings: a social determinants of health lexicon for health care systems. Milbank Q. 2019;97(2):407.
   PubMed Web of Science ®Google Scholar
• Oates GR, Rutland S, Juarez L, et al. The association of area deprivation and state child health with respiratory outcomes of pediatric patients with cystic fibrosis in the United States. Pediatr Pulmonol. 2021;56(5):883–890.
   PubMedGoogle Scholar
• Guth M, Garfield R, Rudowitz R. The effects of medicaid expansion under the ACA: studies from January 2014 to January 2020. 2020 Mar 17.
   Google Scholar
• McKone EF, Ariti C, Jackson A, et al. Survival estimates in European cystic fibrosis patients and the impact of socioeconomic factors: a retrospective registry cohort study. Eur Respir J. 2021;58(3):2002288.
   PubMedGoogle Scholar
• Krieger N, Williams DR, Moss NE. Measuring social class in US public health research: concepts, methodologies, and guidelines. Annu Rev Public Health. 1997;18(1):341–378.
   PubMed Web of Science ®Google Scholar
• Oakes JM, Rossi PH. The measurement of SES in health research: current practice and steps toward a new approach. Soc Sci Med. 2003;56(4):769–784.
   PubMed Web of Science ®Google Scholar
• Spilerman S. Wealth and stratification processes. Annu Rev Sociol. 2000;26(1):497–524.
   Google Scholar
• Braveman PA, Cubbin C, Egerter S, et al. Socioeconomic disparities in health in the United States: what the patterns tell us. Am J Public Health. 2010;100 Suppl 1(S1):S186–96.
   PubMedGoogle Scholar
• Kitagawa EM, Hauser PM. Differential mortality in the United States: a study in socioeconomic epidemiology. Cambridge Mass: Harvard University Press; 1973.
   Google Scholar
• Pappas G, Queen S, Hadden W, et al. The increasing disparity in mortality between socioeconomic groups in the United States, 1960 and 1986. N Engl J Med. 1993;329(2):103–109.
   PubMed Web of Science ®Google Scholar
• Adler NE, Ostrove JM. Socioeconomic status and health: what we know and what we don’t. Socioeconomic Status and Health in Ind Nations. 1999;896:3–15.
   Google Scholar
• Johnson B, Ngueyep R, Schechter MS, et al. Does distance to a cystic fibrosis center impact health outcomes? Pediatr Pulmonol. 2018;53(3):284–292.
   PubMed Web of Science ®Google Scholar
• O’Connor GT, Quinton HB, Kneeland T, et al. Median household income and mortality rate in cystic fibrosis. Pediatrics. 2003;111(4):e333–9.
   PubMedGoogle Scholar
• Taylor-Robinson DC, Smyth RL, Diggle PJ, et al. The effect of social deprivation on clinical outcomes and the use of treatments in the UK cystic fibrosis population: a longitudinal study. Lancet Respir Med. 2013;1(2):121–128
   PubMed Web of Science ®Google Scholar
• Oates GR, Baker E, Rowe SM, et al. Tobacco smoke exposure and socioeconomic factors are independent predictors of pulmonary decline in pediatric cystic fibrosis. J Cyst Fibros. 2020 Feb 17;19(5):783–790. S1569-1993(20)30049-7.
   PubMedGoogle Scholar
• Bustamante AE, Fernandez LT, Rivas LC, et al. Disparities in cystic fibrosis survival in Mexico: impact of socioeconomic status. Pediatr Pulmonol. 2021;56(6):1566–1572.
   PubMedGoogle Scholar
• Sanders DB, Emerson J, Ren CL, et al. Early childhood risk factors for decreased FEV1 at age six to seven years in young children with cystic fibrosis. Ann Am Thorac Soc. 2015;12(8):1170–1176.
   PubMed Web of Science ®Google Scholar
• Britton LJ, Oates GR, Oster RA, et al. Risk stratification model to detect early pulmonary disease in infants with cystic fibrosis diagnosed by newborn screening. Pediatr Pulmonol. 2016;51(11):1168–1176.
   PubMedGoogle Scholar
• Taylor-Robinson DC, Thielen K, Pressler T, et al. Low socioeconomic status is associated with worse lung function in the Danish cystic fibrosis population. Eur Respir J. 2014;44(5):1363–1366.
   PubMedGoogle Scholar
• Britton JR. Effects of social class, sex, and region of residence on age at death from cystic fibrosis. BMJ. 1989;298(6672):483–487.
   PubMed Web of Science ®Google Scholar
• Barr HL, Britton J, Smyth AR, et al. Association between socioeconomic status, sex, and age at death from cystic fibrosis in England and Wales (1959 to 2008): cross sectional study. Br Med J. 2011;343:d4662. doi: https://doi.org/10.1136/bmj.d4662.
   PubMedGoogle Scholar
• Schechter MS, Shelton BJ, Margolis PA, et al. The association of socioeconomic status with outcomes in cystic fibrosis patients in the United States. Am J Respir Crit Care Med. 2001;163(6):1331–1337.
   PubMed Web of Science ®Google Scholar
• Schechter MS, Margolis PA. Relationship between socioeconomic status and disease severity in cystic fibrosis. J Pediatr. 1998;132(2):260–264.
   PubMed Web of Science ®Google Scholar
• Dickinson KM, Psoter KJ, Riekert KA, et al. Association between insurance variability and early lung function in children with cystic fibrosis. J Cyst Fibros. 2021. Jun 23;21(1):104–110. Epub ahead of print. PMID: 34175244. .
   PubMedGoogle Scholar
• Tuchman LK, Schwartz LA, Sawicki GS, et al. Cystic fibrosis and transition to adult medical care. Pediatrics. 2010;125(3):566–573.
   PubMedGoogle Scholar
• Tumin D, Crowley EM, Li SS, et al. Patterns of health insurance coverage and lung disease progression in adolescents and young adults with cystic fibrosis. Ann Am Thorac Soc. 2021;18(2):290–299.
   PubMedGoogle Scholar
• Caldwell SH, Popenoe R. Perceptions and misperceptions of skin color. Ann Intern Med. 1995;122(8):614–617.
   PubMedGoogle Scholar
• Kahn J. How a drug becomes “ethnic”: law, commerce, and the production of racial categories in medicine. Yale J Health Policy Law Ethics. 2004;4(1):1–46.
   PubMedGoogle Scholar
• Hoover EL. There is no scientific rationale for race-based research. J Natl Med Assoc. 2007;99(6):690–692.
   PubMedGoogle Scholar
• Buu MC, Sanders LM, Mayo JA, et al. Assessing differences in mortality rates and risk factors between hispanic and non-hispanic patients with cystic fibrosis in California. Chest. 2016;149(2):380–389.
   PubMed Web of Science ®Google Scholar
• Hamosh A, FitzSimmons SC, Macek M Jr. , et al. Comparison of the clinical manifestations of cystic fibrosis in black and white patients. J Pediatr. 1998;132(2):255–259.
   PubMed Web of Science ®Google Scholar
• Kopp BT, Nicholson L, Paul G, et al. The geographic impact on hospitalization in patients with cystic fibrosis. J Pediatr. 2016;170:246–252.
   PubMedGoogle Scholar
• McGarry ME, Neuhaus JM, Nielson DW, et al. Pulmonary function disparities exist and persist in hispanic patients with cystic fibrosis: a longitudinal analysis. Pediatr Pulmonol. 2017;52(12):1550–1557.
   PubMedGoogle Scholar
• McGarry ME, Neuhaus JM, Nielson DW, et al. Regional variations in longitudinal pulmonary function: a comparison of hispanic and non-hispanic subjects with cystic fibrosis in the United States. Pediatr Pulmonol. 2019;54(9):1382–1390.
   PubMedGoogle Scholar
• Rho J, Ahn C, Gao A, et al. Disparities in mortality of hispanic patients with cystic fibrosis in the United States. A national and regional cohort study. Am J Respir Crit Care Med. 2018;198(8):1055–1063.
   PubMedGoogle Scholar
• Watts KD, Seshadri R, Sullivan C, et al. Increased prevalence of risk factors for morbidity and mortality in the US Hispanic CF population. Pediatr Pulmonol. 2009;44(6):594–601.
   PubMed Web of Science ®Google Scholar
• Williams DR. Race, socioeconomic status, and health. The added effects of racism and discrimination. Ann N Y Acad Sci. 1999;896(1):173–188.
   PubMed Web of Science ®Google Scholar
• Quittner AL, Schechter MS, Rasouliyan L, et al. Impact of socioeconomic status, race, and ethnicity on quality of life in patients with cystic fibrosis in the United States. Chest. 2010;137(3):642–650.
   PubMed Web of Science ®Google Scholar
• Definitions of Food Insecurity. United States department of agriculture economic research service. [cited 2021 Oct 1]. Available at: https://www.ers.usda.gov/topics/food-nutrition-assistance/food-security-in-the-us/definitions-of-food-security.aspx.
   Google Scholar
• McDonald CM, Christensen NK, Lingard C, et al. Nutrition knowledge and confidence levels of parents of children with cystic fibrosis. ICAN: Infant, Child, & Adolescent Nutrition. 2009;1(6):325–331.
   Google Scholar
• Dubowitz T, Zenk SN, Ghosh-Dastidar B, et al. Healthy food access for urban food desert residents: examination of the food environment, food purchasing practices, diet and BMI. Public Health Nutr. 2015;18(12):2220–2230.
   PubMed Web of Science ®Google Scholar
• Walker RE, Keane CR, Burke JG. Disparities and access to healthy food in the United States: a review of food deserts literature. Health Place. 2010;16(5):876–884.
   PubMed Web of Science ®Google Scholar
• Taylor-Robinson D, Whitehead M, Diggle P, et al. The effect of social deprivation on weight in the UK cystic fibrosis population. J Epidemiol Community Health. 2011;65(Suppl 1):A389–A.
   PubMedGoogle Scholar
• Pinto IC, Silva CP, Britto MC. Nutritional, clinical and socioeconomic profile of patients with cystic fibrosis treated at a referral center in northeastern Brazil. J Bras Pneumol. 2009;35(2):137–143.
   PubMed Web of Science ®Google Scholar
• Balmer DF, Schall JI, Stallings VA. Social disadvantage predicts growth outcomes in preadolescent children with cystic fibrosis. J Cyst Fibros. 2008;7(6):543–550.
   PubMed Web of Science ®Google Scholar
• Brown PS, Durham D, Tivis RD, et al. Evaluation of food insecurity in adults and children with cystic fibrosis: community case study. Front Public Health. 2018;6:348.
   PubMedGoogle Scholar
• Moss RB. Fungi in cystic fibrosis and non–cystic fibrosis bronchiectasis. Semin Respir Crit Care Med. 2015;36(2):207–216.
   PubMedGoogle Scholar
• Rocchi S, Richaud-Thiriez B, Barrera C, et al. Evaluation of mold exposure in cystic fibrosis patients‘ dwellings and allergic bronchopulmonary risk. J Cyst Fibros. 2015;14(2):242–247.
   PubMed Web of Science ®Google Scholar
• Molina AL, Molina Y, Walley SC, et al. Residential instability, neighborhood deprivation, and pediatric asthma outcomes. Pediatr Pulmonol. 2020;55(6):1340–1348.
   PubMed Web of Science ®Google Scholar
• Anderson KM, Institute of medicine roundtable on the promotion of health equity and the elimination of health disparities. How far have we come in reducing health disparities? Progress since 2000: Workshop summary. Washington, D. C. : National Academies Press; 2012.
   Google Scholar
• Franco M, Diez Roux AV, Glass TA, et al. Neighborhood characteristics and availability of healthy foods in Baltimore. Am J Prev Med. 2008;35(6):561–567.
   PubMed Web of Science ®Google Scholar
• Moore LV, Diez Roux AV. Associations of neighborhood characteristics with the location and type of food stores. Am J Public Health. 2006;96(2):325–331.
   PubMed Web of Science ®Google Scholar
• Miller M, Middendorf G, Wood SD. Food availability in the heartland: exploring the effects of neighborhood racial and income composition. Rural Sociol. 2015;80(3):340–361.
   Google Scholar
• Jennings V, Baptiste AK, Osborne Jelks N, et al. Urban Green Space and the Pursuit of Health Equity in Parts of the United States. Int J Environ Res Public Health. 2017;14(11):1432.
   Web of Science ®Google Scholar
• Sampson RJ, Morenoff JD, Raudenbush S. Social anatomy of racial and ethnic disparities in violence. Am J Public Health. 2005;95(2):224–232.
   PubMed Web of Science ®Google Scholar
• Salas-Wright CP, Nelson EJ, Vaughn MG, et al. Trends in fighting and violence among adolescents in the United States, 2002-2014. Am J Public Health. 2017;107(6):977–982.
   PubMedGoogle Scholar
• Bogar S, Beyer KM. Green space, violence, and crime: a systematic review. Trauma Violence Abuse. 2016;17(2):160–171.
   PubMed Web of Science ®Google Scholar
• Han B, Cohen DA, Derose KP, et al. Violent crime and park use in low-income urban neighborhoods. Am J Prev Med. 2018;54(3):352–358.
   PubMedGoogle Scholar
• Rhone A, Ver Ploeg M, Williams R, et al. Understanding low-income and low-access census tracts across the nation subnational and subpopulation estimates of access to healthy food. Washington, DC: United States Department of Agriculture, Economic Research Service; 2019.
   Google Scholar
• Kolak M, Bhatt J, Park YH, et al. Quantification of neighborhood-level social determinants of health in the continental United States. JAMA Network Open. 2020;3(1):e1919928.
   PubMed Web of Science ®Google Scholar
• Gustafsson PE, San Sebastian M, Janlert U, et al. Life-course accumulation of neighborhood disadvantage and allostatic load: empirical integration of three social determinants of health frameworks. Am J Public Health. 2014;104(5):904–910.
   PubMed Web of Science ®Google Scholar
• Ludwig J, Duncan GJ, Gennetian LA, et al. Neighborhood effects on the long-term well-being of low-income adults. Science. 2012;337(6101):1505–1510.
   PubMed Web of Science ®Google Scholar
• Shmool JL, Kubzansky LD, Newman OD, et al. Social stressors and air pollution across New York City communities: a spatial approach for assessing correlations among multiple exposures. Environ Health. 2014;13(1):91.
   PubMedGoogle Scholar
• Beck AF, Huang B, Ryan PH, et al. Areas with high rates of police-reported violent crime have higher rates of childhood asthma morbidity. J Pediatr. 2016;173:175–82 e1.
   PubMed Web of Science ®Google Scholar
• Koinis-Mitchell D, Kopel SJ, Salcedo L, et al. Asthma indicators and neighborhood and family stressors related to urban living in children. Am J Health Behav. 2014;38(1):22–30.
   PubMed Web of Science ®Google Scholar
• Vangeepuram N, Galvez MP, Teitelbaum SL, et al. The association between parental perception of neighborhood safety and asthma diagnosis in ethnic minority urban children. J Urban Health. 2012;89(5):758–768.
   PubMedGoogle Scholar
• Ramratnam SK, Han YY, Rosas-Salazar C, et al. Exposure to gun violence and asthma among children in Puerto Rico. Respir Med. 2015;109(8):975–981.
   PubMedGoogle Scholar
• Rosas-Salazar C, Han YY, Brehm JM, et al. Gun violence, African ancestry, and asthma: a case-control study in Puerto Rican children. Chest. 2016;149(6):1436–1444.
   PubMedGoogle Scholar
• Chen E, Chim LS, Strunk RC, et al. The role of the social environment in children and adolescents with asthma. Am J Respir Crit Care Med. 2007;176(7):644–649.
   PubMed Web of Science ®Google Scholar
• Alcock I, White M, Cherrie M, et al. Land cover and air pollution are associated with asthma hospitalisations: a cross-sectional study. Environ Int. 2017;109:29–41.
   PubMed Web of Science ®Google Scholar
• Tischer C, Gascon M, Fernandez-Somoano A, et al. Urban green and grey space in relation to respiratory health in children. Eur Respir J. 2017;49(6):1502112.
   PubMed Web of Science ®Google Scholar
• Alexander D, Currie J. Is it who you are or where you live? Residential segregation and racial gaps in childhood asthma. J Health Econ. 2017;55:186–200.
   PubMedGoogle Scholar
• Woo H, Brigham EP, Allbright K, et al. Racial segregation and respiratory outcomes among urban black residents with and at risk of COPD. Am J Respir Crit Care Med. 2021;204(5):536–545.
   PubMedGoogle Scholar
• Szczesniak R, Rice JL, Brokamp C, et al. * Influences of environmental exposures on individuals living with cystic fibrosis. Expert Rev Respir Med. 2020;14(7):737–748.
   PubMed Web of Science ®Google Scholar
• Schraufnagel DE, Balmes JR, Cowl CT, et al. Air pollution and noncommunicable diseases: a review by the forum of international respiratory societies’ environmental committee, Part 1: the damaging effects of air pollution. Chest. 2019;155(2):409–416.
   PubMed Web of Science ®Google Scholar
• Schraufnagel DE, Balmes JR, Cowl CTet al . Air Pollution and Noncommunicable Diseases: a Review by the Forum of International Respiratory Societies. Environmental Committee, Part 2: Air Pollution and Organ Systems. Chest. 2019;155(2):417–426.
   Google Scholar
• U.S. Department of Health and Human Services. Smoking Cessation. A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. 2020.
   Google Scholar
• Ong T, Schechter M, Yang J, et al. Socioeconomic status, smoke exposure, and health outcomes in young children with cystic fibrosis. Pediatrics. 2017;139(2).
   Web of Science ®Google Scholar
• Raju SV, Rasmussen L, Sloane PA, et al. Roflumilast reverses CFTR-mediated ion transport dysfunction in cigarette smoke-exposed mice. Respir Res. 2017;18(1):173.
   PubMedGoogle Scholar
• Rab A, Rowe SM, Raju SV, et al. Cigarette smoke and CFTR: implications in the pathogenesis of COPD. Am J Physiol Lung Cell Mol Physiol. 2013;305(8):L530–41.
   PubMed Web of Science ®Google Scholar
• Rasmussen JE, Sheridan JT, Polk W, et al. Cigarette smoke-induced Ca2+ release leads to cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction. J Biol Chem. 2014;289(11):7671–7681.
   PubMed Web of Science ®Google Scholar
• Raju SV, Jackson PL, Courville CA, et al. Cigarette smoke induces systemic defects in cystic fibrosis transmembrane conductance regulator function. Am J Respir Crit Care Med. 2013;188(11):1321–1330.
   PubMed Web of Science ®Google Scholar
• Sloane PA, Shastry S, Wilhelm A, et al. A pharmacologic approach to acquired cystic fibrosis transmembrane conductance regulator dysfunction in smoking related lung disease. PLoS One. 2012;7(6):e39809.
   PubMedGoogle Scholar
• Cantin AM, Hanrahan JW, Bilodeau G, et al. Cystic fibrosis transmembrane conductance regulator function is suppressed in cigarette smokers. Am J Respir Crit Care Med. 2006;173(10):1139–1144.
   PubMed Web of Science ®Google Scholar
• Kreindler JL, Jackson AD, Kemp PA, et al. Inhibition of chloride secretion in human bronchial epithelial cells by cigarette smoke extract. Am J Physiol Lung Cell Mol Physiol. 2005;288(5):L894–902.
   PubMedGoogle Scholar
• Clunes LA, Davies CM, Coakley RD, et al. Cigarette smoke exposure induces CFTR internalization and insolubility, leading to airway surface liquid dehydration. FASEB J. 2012;26(2):533–545.
   PubMed Web of Science ®Google Scholar
• Savitski AN, Mesaros C, Blair IA, et al. Secondhand smoke inhibits both Cl- and K+ conductances in normal human bronchial epithelial cells. Respir Res. 2009;10(1):120.
   PubMedGoogle Scholar
• Lin VY, Fain MD, Jackson PL, et al. Vaporized E-cigarette liquids induce ion transport dysfunction in airway epithelia. Am J Respir Cell Mol Biol. 2019;61(2):162–173.
   PubMedGoogle Scholar
• Dransfield MT, Wilhelm AM, Flanagan B, et al. Acquired CFTR dysfunction in the lower airways in COPD. Chest. 2013;144(2):498–506.
   PubMedGoogle Scholar
• Ni I, Ji C, Vij N. Second-hand cigarette smoke impairs bacterial phagocytosis in macrophages by modulating CFTR dependent lipid-rafts. PLoS One. 2015;10(3):e0121200.
   PubMed Web of Science ®Google Scholar
• Kopp BT, Thompson R, Kim J, et al. Secondhand smoke alters arachidonic acid metabolism and inflammation in infants and children with cystic fibrosis. Thorax. 2019;74(3):237–246.
   PubMed Web of Science ®Google Scholar
• Kopp BT, Sarzynski L, Khalfoun S, et al. Detrimental effects of secondhand smoke exposure on infants with cystic fibrosis. Pediatr Pulmonol. 2015;50(1):25–34.
   PubMed Web of Science ®Google Scholar
• Schechter MS. Nongenetic influences on cystic fibrosis outcomes. Curr Opin Pulm Med. 2011;17(6):448–454.
   PubMed Web of Science ®Google Scholar
• Rubin BK. Exposure of children with cystic fibrosis to environmental tobacco smoke. N Engl J Med. 1990;323(12):782–788.
   PubMed Web of Science ®Google Scholar
• Schechter MS, Braveman P, Egerter S. Speaking of pandemics. J Cyst Fibros. 2021;20(4):564–565.
   PubMedGoogle Scholar
• Baker E, Harris WT, Rowe SM, et al. * Tobacco smoke exposure limits the therapeutic benefit of tezacaftor/ivacaftor in pediatric patients with cystic fibrosis. J Cyst Fibros. 2021 Jul;20(4):612–617.
   PubMedGoogle Scholar
• Oates GR, Baker E, Collaco JM, et al. *Cessation of smoke exposure improves pediatric CF outcomes: longitudinal analysis of CF foundation patient registry data. J Cyst Fibros. 2021 Jul;20(4):618–624.
   PubMedGoogle Scholar
• Wheeler BW. Environmental equity, air quality, socioeconomic status, and respiratory health: a linkage analysis of routine data from the health survey for England. J Epidemiol Community Health. 2005;59(11):948–954.
   PubMed Web of Science ®Google Scholar
• Hajat A, Hsia C, O’Neill MS. Socioeconomic disparities and air pollution exposure: a global review. Curr Environ Health Rep. 2015;2(4):440–450.
   PubMedGoogle Scholar
• Ard K. Trends in exposure to industrial air toxins for different racial and socioeconomic groups: a spatial and temporal examination of environmental inequality in the U. S. from 1995 to 2004. Soc Sci Res. 2015;53:375–390.
   PubMed Web of Science ®Google Scholar
• Deguen S, Petit C, Delbarre A, et al. Neighbourhood characteristics and long-term air pollution levels modify the association between the short-term nitrogen dioxide concentrations and all-cause mortality in Paris. PLoS One. 2015;10(7):e0131463.
   PubMed Web of Science ®Google Scholar
• Gauderman WJ, Avol E, Gilliland F, et al. The effect of air pollution on lung development from 10 to 18 years of age. N Engl J Med. 2004;351(11):1057–1067.
   PubMed Web of Science ®Google Scholar
• Pope CA, Thun MJ, Namboodiri MM, et al. Particulate air-pollution as a predictor of mortality in a prospective-study of us adults. Am J Respir Crit Care Med. 1995;151(3):669–674.
   PubMed Web of Science ®Google Scholar
• Hooper LG, Kaufman JD. Ambient air pollution and clinical implications for susceptible populations. Ann Am Thorac Soc. 2018;15(Suppl 2):S64–S8.
   PubMedGoogle Scholar
• Farhat SCL, Almeida MB, Silva-Filho LVRF, et al. Ozone is associated with an increased risk of respiratory exacerbations in patients with cystic fibrosis. Chest. 2013 Oct;144(4):1186–1192.
   PubMed Web of Science ®Google Scholar
• Goeminne PC, Kicinski M, Vermeulen F, et al. , * Impact of air pollution on cystic fibrosis pulmonary exacerbations: a case-crossover analysis. Chest. 143(4): 946–954. 2013. .
   PubMed Web of Science ®Google Scholar
• Goss CH, Newsom SA, Schildcrout JS, et al. Effect of ambient air pollution on pulmonary exacerbations and lung function in cystic fibrosis. Am J Respir Crit Care Med. 2004;169(7):816–821.
   PubMed Web of Science ®Google Scholar
• Psoter KJ, De Roos AJ, Mayer JD, et al. Fine particulate matter exposure and initial Pseudomonas aeruginosa acquisition in cystic fibrosis. Ann Am Thorac Soc. 2015;12(3):385–391.
   PubMed Web of Science ®Google Scholar
• Kosorok MR, Jalaluddin M, Farrell PM, et al. Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis. Pediatr Pulmonol. 1998;26(2):81–88.
   PubMed Web of Science ®Google Scholar
• Jennings MT, Dasenbrook EC, Lechtzin N, et al. Risk factors for persistent methicillin-resistant Staphylococcus aureus infection in cystic fibrosis. J Cyst Fibros. 2017;16(6):681–686.
   PubMed Web of Science ®Google Scholar
• Oates GR, Harris WT, Rowe SM, et al. Area deprivation as a risk factor for methicillin-resistant staphylococcus aureus infection in pediatric cystic fibrosis. Pediatr Infect Dis J. 2019;38(11):e285–e9.
   PubMed Web of Science ®Google Scholar
• Sawicki GS, Sellers DE, Robinson WM. High treatment burden in adults with cystic fibrosis: challenges to disease self-management. J Cyst Fibros. 2009;8(2):91–96.
   PubMed Web of Science ®Google Scholar
• Eakin MN, Bilderback A, Boyle MP, et al. Longitudinal association between medication adherence and lung health in people with cystic fibrosis. J Cystic Fibrosis. 2011;10(4):258–264.
   PubMed Web of Science ®Google Scholar
• Briesacher BA, Quittner AL, Saiman L, et al. Adherence with tobramycin inhaled solution and health care utilization. BMC Pulm Med. 2011;11(1):5.
   PubMedGoogle Scholar
• Apter AJ, Reisine ST, Affleck G, et al. Adherence with twice-daily dosing of inhaled steroids. Socioeconomic and health-belief differences. Am J Respir Crit Care Med. 1998;157(6 Pt 1):1810–1817.
   PubMed Web of Science ®Google Scholar
• Rapoff MA, Belmont JM, Lindsley CB, et al. Electronically monitored adherence to medications by newly diagnosed patients with juvenile rheumatoid arthritis. Arthritis & Rheumatism-Arthritis Care & Res. 2005;53(6):905–910.
   Web of Science ®Google Scholar
• Oates GR, Juarez LD, Hansen B, et al. Social risk factors for medication nonadherence: findings from the CARDIA study. Am J Health Behav. 2020;44(2):232–243.
   PubMedGoogle Scholar
• Goldman DP, Smith JP. Can patient self-management help explain the SES health gradient? Proc Natl Acad Sci U S A. 2002;99(16):10929–10934.
   PubMed Web of Science ®Google Scholar
• Ievers CE, Brown RT, Drotar D, et al. Knowledge of physician prescriptions and adherence to treatment among children with cystic fibrosis and their mothers. J Dev Behav Pediatr. 1999;20(5):335–343.
   PubMed Web of Science ®Google Scholar
• Lask B. Non-adherence to treatment in cystic fibrosis. J R Soc Med. 1994;87:25–27.
   PubMed Web of Science ®Google Scholar
• Anthony H, Paxton S, Bines J, et al. Psychosocial predictors of adherence to nutritional recommendations and growth outcomes in children with cystic fibrosis. J Psychosom Res. 1999;47(6):623–634.
   PubMed Web of Science ®Google Scholar
• Quittner AL, Drotar D, Ievers-Landis C. Adherence to medical treatments in adolescents with cystic fibrosis: the development and evaluation of family based interventions. In: Drotar D, editor. Promoting adherence to medical treatment in childhood chronic illness: concepts, methods, and interventions. Hillsdale New Jersey: Erlbaum Associates, Inc; 2000;340–364.
   Google Scholar
• Patterson JM, Goetz D, Budd J, et al. Family correlates of a 10-year pulmonary health trend in cystic fibrosis. Pediatrics. 1993;91(2):383–389.
   PubMed Web of Science ®Google Scholar
• Patterson JM, McCubbin HI, Warwick WJ. The impact of family functioning on health changes in children with cystic fibrosis. Soc Sci Med. 1990;31(2):159–164.
   PubMedGoogle Scholar
• Eddy ME, Carter BD, Kronenberger WG, et al. Parent relationships and compliance in cystic fibrosis. J Pediatr Health Care. 1998;12(4):196–202.
   PubMedGoogle Scholar
• Pendleton DA, David TJ. The compliance conundrum in cystic fibrosis. J R Soc Med. 2000;93(Suppl 38):9–13.
   PubMed Web of Science ®Google Scholar
• Schechter MS. Non-genetic influences on cystic fibrosis lung disease: the role of sociodemographic characteristics, environmental exposures, and healthcare interventions. Semin Respir Crit Care Med. 2003;24(6):639–652.
   PubMed Web of Science ®Google Scholar
• Macpherson C, Redmond AO, Leavy A, et al. A review of cystic fibrosis children born to single mothers. Acta Paediatr. 1998;87(4):397–400.
   PubMed Web of Science ®Google Scholar
• Oates GR, Stepanikova I, Gamble S, et al. Adherence to airway clearance therapy in pediatric cystic fibrosis: socioeconomic factors and respiratory outcomes. Pediatr Pulmonol. 2015;50(12):1244–1252.
   PubMed Web of Science ®Google Scholar
• Hodgkinson R, Lester H. Stresses and coping strategies of mothers living with a child with cystic fibrosis: implications for nursing professionals. J Adv Nurs. 2002;39(4):377–383.
   PubMed Web of Science ®Google Scholar
• Quittner AL, Opipari LC, Regoli MJ, et al. The impact of caregiving and role strain on family life: comparisons between mothers of children with cystic fibrosis and matched controls. Rehabil Psychol. 1992;37(4):275–290.
   Web of Science ®Google Scholar
• Pearlin L. The sociological study of stress. J Health Soc Behav. 1989;30(3):241–256.
   PubMed Web of Science ®Google Scholar
• Turner RJ, Wheaton B, Lloyd DA. The epidemiology of social stress. Am Sociol Rev. 1995;60(1):104–125.
   Web of Science ®Google Scholar
• Kubzansky LD, Kawachi I, Sparrow D. Socioeconomic status, hostility, and risk factor clustering in the normative aging study: any help from the concept of allostatic load? Ann Behav Med. 1999;21(4):330–338.
   PubMed Web of Science ®Google Scholar
• Pearlin L, Schieman S, Fazio EM, et al. Stress, health, and the life course: some conceptual perspectives. J Health Soc Behav. 2005;46(2):205–219.
   PubMed Web of Science ®Google Scholar
• Berkman LF, Kawachi I. Social epidemiology. New York: Oxford University Press; 2000.
   Google Scholar
• Thoits PA. Stress and health: major findings and policy implications. J Health Soc Behav. 2010;51(Suppl):S41–53.
   PubMed Web of Science ®Google Scholar
• McEwen BS, Seeman T. Protective and damaging effects of mediators of stress. Elaborating and testing the concepts of allostasis and allostatic load. Ann N Y Acad Sci. 1999;896(1):30–47.
   PubMed Web of Science ®Google Scholar
• Seeman TE, McEwen BS, Rowe JW, et al. Allostatic load as a marker of cumulative biological risk: macArthur studies of successful aging. Proc Natl Acad Sci USA. 2001;98(8):4770–4775.
   PubMed Web of Science ®Google Scholar
• Evans GW, Kim P. Multiple risk exposure as a potential explanatory mechanism for the socioeconomic status-health gradient. Ann NY Acad Sci. 2010;1186(1):174–189.
   PubMed Web of Science ®Google Scholar
• Harper S, Lynch J, Hsu WL, et al. Life course socioeconomic conditions and adult psychosocial functioning. Int J Epidemiol. 2002;31(2):395–403.
   PubMed Web of Science ®Google Scholar
• Everhart RS, Fiese BH, Smyth JM, et al. Family functioning and treatment adherence in children and adolescents with cystic fibrosis. Pediatr Allergy Immunol Pulmonol. 2014;27(2):82–86.
   PubMed Web of Science ®Google Scholar
• Cruz I, Marciel KK, Quittner AL, et al. Anxiety and depression in cystic fibrosis. Semin Respir Crit Care Med. 2009;30(5):569–578.
   PubMed Web of Science ®Google Scholar
• Bittman M, Hill T, Thomson C. The impact of caring on informal carers’ employment, income and earnings: a longitudinal approach. Australian J of Social Issues. 2007;42(2):255–272.
   Web of Science ®Google Scholar
• Vitaliano PP, Zhang J, Scanlan JM. Is caregiving hazardous to one’s physical health? A meta-analysis. Psychol Bull. 2003;129(6):129 946–72.
   PubMedGoogle Scholar
• Pinquart M, Sorensen S. Differences between caregivers and noncaregivers in psychological health and physical health: a meta-analysis. Psychol Aging. 2003;18(2):250–267.
   PubMed Web of Science ®Google Scholar
• Neri L, Lucidi V, Catastini P, et al. Caregiver burden and vocational participation among parents of adolescents with CF. Pediatr Pulmonol. 2016;51(3):243–252.
   PubMed Web of Science ®Google Scholar
• Schechter MS, Cruz I, Blackwell LS, et al. Risk factors for anxiety and depression in cystic fibrosis. Pediatr Pulmonol. 2010;Supple 33:109–110.
   Google Scholar
• Besier T, Goldbeck L. Anxiety and depression in adolescents with CF and their caregivers. J Cyst Fibros. 2011;10(6):435–442.
   PubMed Web of Science ®Google Scholar
• Yohannes AM, Willgoss TG, Fatoye FA, et al. Relationship between anxiety, depression, and quality of life in adult patients with cystic fibrosis. Respir Care. 2012;57(4):550–556.
   PubMed Web of Science ®Google Scholar
• Schechter MS, Ostrenga JS, Fink AK, et al. Decreased survival in cystic fibrosis patients with a positive screen for depression. J Cyst Fibros. 2021;20(1):120–126.
   PubMed Web of Science ®Google Scholar
• Foster C, Eiser C, Oades P, et al. Treatment demands and differential treatment of patients with cystic fibrosis and their siblings: patient, parent and sibling accounts. Child Care Health Dev. 2001;27(4):349–364.
   PubMed Web of Science ®Google Scholar
• Barker DH, Driscoll KA, Modi AC, et al. Supporting cystic fibrosis disease management during adolescence: the role of family and friends. Child Care Health Dev. 2012;38(4):497–504.
   PubMed Web of Science ®Google Scholar
• Flewelling KD, Sellers DE, Sawicki GS, et al. Social support is associated with fewer reported symptoms and decreased treatment burden in adults with cystic fibrosis. J Cyst Fibros. 2019;18(4):572–576.
   PubMedGoogle Scholar
• Crowley EM, Bosslet GT, Khan B, et al. Social complexity negatively influences lung function in cystic fibrosis after transfer to adult care. Pediatr Pulmonol. 2020;55(1):24–26.
   PubMedGoogle Scholar
• Crowley EM, Bosslet GT, Khan B, et al. Impact of social complexity on outcomes in cystic fibrosis after transfer to adult care. Pediatr Pulmonol. 2018;53(6):735–740.
   PubMedGoogle Scholar
• Schechter MS, McColley SA, Silva S, et al. *Association of socioeconomic status with the use of chronic therapies and healthcare utilization in children with cystic fibrosis. J Pediatr. 2009;155(5):634–639.
   PubMed Web of Science ®Google Scholar
• Schechter MS, McColley SA, Regelmann W, et al. *Socioeconomic status and the likelihood of antibiotic treatment for signs and symptoms of pulmonary exacerbation in children with cystic fibrosis. J Pediatr. 2011;159(5):819–824.
   PubMed Web of Science ®Google Scholar
• Li SS, Hayes D Jr. , Tobias JD, et al. Health insurance and use of recommended routine care in adults with cystic fibrosis. Clin Respir J. 2018;12(5):1981–1988.
   PubMedGoogle Scholar
• Stephenson A, Hux J, Tullis E, et al. Socioeconomic status and risk of hospitalization among individuals with cystic fibrosis in Ontario, Canada. Pediatr Pulmonol. 2011;46(4):376–384.
   PubMed Web of Science ®Google Scholar
• Ramos KJ, Quon BS, Psoter KJ, et al. Predictors of non-referral of patients with cystic fibrosis for lung transplant evaluation in the United States. J Cyst Fibros. 2016;15(2):196–203.
   PubMed Web of Science ®Google Scholar
• Quon BS, Psoter K, Mayer-Hamblett N, et al. Disparities in access to lung transplantation for patients with cystic fibrosis by socioeconomic status. Am J Respir Crit Care Med. 2012;186(10):1008–1013.
   PubMed Web of Science ®Google Scholar
• Lehr CJ, Fink AK, Skeans M, et al. , * Impact of Socioeconomic Position on Access to the U. S. Lung Transplant Waiting List in a Matched Cystic Fibrosis Cohort. Ann Am Thorac Soc. 17(11): 1384–1392. 2020. .
   PubMedGoogle Scholar
• Krivchenia K, Tumin D, Tobias JD, et al. Increased mortality in adult cystic fibrosis patients with medicaid insurance awaiting lung transplantation. Lung. 2016;194(5):799–806.
   PubMed Web of Science ®Google Scholar
• Merlo CA, Clark SC, Arnaoutakis GJ, et al. National healthcare delivery systems influence lung transplant outcomes for cystic fibrosis. Am J Transplant. 2015;15(7):1948–1957.
   PubMed Web of Science ®Google Scholar
• Hyde R, Dobrovolny D. Orphan drug pricing and payer management in the United States: are we approaching the tipping point? Am Health Drug Benefits. 2010;3(1):15–23.
   PubMedGoogle Scholar
• Kanavos P, Nicod E. What is wrong with orphan drug policies? Suggestions for ways forward. Value Health. 2012;15(8):1182–1184.
   PubMed Web of Science ®Google Scholar
• Goss CH, Rubenfeld GD, Ramsey BW, et al. Clinical trial participants compared with nonparticipants in cystic fibrosis. Am J Respir Crit Care Med. 2006;173(1):98–104.
   PubMed Web of Science ®Google Scholar
• McGarry ME, McColley SA. Minorities are underrepresented in clinical trials of pharmaceutical agents for cystic fibrosis. Ann Am Thorac Soc. 2016;13(10):1721–1725.
   PubMedGoogle Scholar
• Final Report of the Commission on Social Determinants of Health. Geneva, Switzerland World Health Organization, 2008.
   Google Scholar
• Taylor-Robinson D, Schechter MS. Health inequalities and cystic fibrosis. BMJ. 2011;343(aug23 3):d4818.
   PubMedGoogle Scholar
• What Is Compass? Cystic Fibrosis Foundation. [cited 2021 Oct 1]. Available from: https://www.cff.org/Assistance-Services/About-Compass/What-Is-Compass.
   Google Scholar
• Baer TE, Gottlieb L, Sandel M. Addressing social determinants of health in the adolescent medical home. Curr Opin Pediatr. 2013;25(4):447–453.
   PubMedGoogle Scholar
• Gottlieb L, Sandel M, Adler NE. Collecting and applying data on social determinants of health in health care settings. JAMA Intern Med. 2013;173(11):1017–1020.
   PubMed Web of Science ®Google Scholar
• Schickedanz A, Hamity C, Rogers A, et al. Clinician experiences and attitudes regarding screening for social determinants of health in a large integrated health system. Med Care. 2019;57 Suppl 6 Suppl 2(Suppl 2):S197–S201.
   Google Scholar
• Byhoff E, Garg A, Pellicer M, et al. Provider and staff feedback on screening for social and behavioral determinants of health for pediatric patients. J Am Board Fam Med. 2019;32(3):297–306.
   PubMedGoogle Scholar
• Colvin JD, Bettenhausen JL, Anderson-Carpenter KD, et al. Multiple behavior change intervention to improve detection of unmet social needs and resulting resource referrals. Acad Pediatr. 2016;16(2):168–174.
   PubMedGoogle Scholar
• Herrera CN, Brochier A, Pellicer M, et al. Implementing social determinants of health screening at community health centers: clinician and staff perspectives. J Prim Care Community Health. 2019;10:2150132719887260.
   Google Scholar
• Garg A, Boynton-Jarrett R, Dworkin PH. Avoiding the unintended consequences of screening for social determinants of health. JAMA. 2016;316(8):813–814.
   PubMed Web of Science ®Google Scholar
• Kreuter M, Garg R, Thompson T, et al. Assessing the capacity of local social services agencies to respond to referrals from health care providers. Health Aff (Millwood). 2020;39(4):679–688.
   PubMedGoogle Scholar
• Fiore M. United States. Tobacco use and dependence guideline panel. Treating tobacco use and dependence: 2008 update. Rockville Md: U. S. Dept. of Health and Human Services; 2008.
   Google Scholar
• Prochaska JJ, Benowitz NL. The past, present, and future of nicotine addiction therapy. Annu Rev Med. 2016;67(1):467–486.
   PubMedGoogle Scholar
• Oates GR, Harris WT, Gutierrez HH, et al. Tobacco smoke exposure in pediatric cystic fibrosis: a qualitative study of clinician and caregiver perspectives on smoking cessation. Pediatr Pulmonol. 2020;55(9):2330–2340.
   PubMedGoogle Scholar
• Frankowski BL, Weaver SO, Secker-Walker RH. Advising parents to stop smoking: pediatricians’ and parents’ attitudes. Pediatrics. 1993;91(2):296–300.
   PubMed Web of Science ®Google Scholar
• Sawicki GS, Fink AK, Schechter MS, et al. Rate and predictors of prescription of lumacaftor-ivacaftor in the 18 months following approval in the United States. J Cyst Fibros. 2018;17(6):742–746.
   PubMedGoogle Scholar
• Sawicki GS, Dasenbrook E, Fink AK, et al. Rate of uptake of ivacaftor use after u. s. food and drug administration approval among patients enrolled in the U. S. cystic fibrosis foundation patient registry. Ann Am Thorac Soc. 2015;12(8):1146–1152.
   PubMedGoogle Scholar
• Yin HS, Dreyer BP, Vivar KL, et al. Perceived barriers to care and attitudes towards shared decision-making among low socioeconomic status parents: role of health literacy. Acad Pediatr. 2012;12(2):117–124.
   PubMed Web of Science ®Google Scholar
• Schechter M, Hendrickson K. Impact of improved reliability and outcomes of cf care on socioeconomic disparities. Pediatr Pulmonol. 2019;54:835.
   Google Scholar
• DiGirolamo M, Kang L, Schechter M. QI-induced improvements may lead to a reduction of socioeconomic disparities in cf health outcomes. Pediatr Pulmonol. 2020;55:331.
   Google Scholar
• Quittner AL, Abbott J, Georgiopoulos AM, et al. International committee on mental health in cystic fibrosis: cystic fibrosis foundation and European cystic fibrosis society consensus statements for screening and treating depression and anxiety. Thorax. 2016;71(1):26–34.
   PubMed Web of Science ®Google Scholar
• Quittner AL, Abbott J, Hussain S, et al. Integration of mental health screening and treatment into cystic fibrosis clinics: evaluation of initial implementation in 84 programs across the United States. Pediatr Pulmonol. 2020;55(11):2995–3004.
   PubMedGoogle Scholar